Science Explorer Back to mapMap

Most cited papers from Yorkshire Cancer Research

What are the most cited papers from Yorkshire Cancer Research?

The most cited paper from Yorkshire Cancer Research is "Mutations of the BRAF gene in human cancer" (Helen Ruth Davies et al., 2002), with 10,791 citations. Next come "Prospective Identification of Tumorigenic Prostate Cancer Stem Cells" (2,826) and "Metastatic bone disease: clinical features, pathophysiology and treatment strategies" (1,942).

Showing 50 of 60 papers. Every paper with more than 200 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Mutations of the BRAF gene in human cancer Helen Ruth Davies et al. · Nature Jun 2002 10,791
2 Prospective Identification of Tumorigenic Prostate Cancer Stem Cells Anne T. Collins, Paul A. Berry, Catherine Hyde et al. · Cancer Research Dec 2005 2,826
3 Metastatic bone disease: clinical features, pathophysiology and treatment strategies Robert Edward Coleman · Cancer Treatment Reviews Jun 2001 1,942
4 High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma J. Anthony Child, Gareth John Morgan, Faith E. Davies et al. · New England Journal of Medicine Open access 7 May 2003 1,774
5 The present and future role of photodynamic therapy in cancer treatment Stanley B. Brown, Elizabeth A. Brown, Ian O. Walker · The Lancet Oncology Aug 2004 1,772
6 Skeletal complications of malignancy Robert Edward Coleman · Cancer 15 Oct 1997 1,454
7 Measuring Quality of Life in Routine Oncology Practice Improves Communication and Patient Well-Being: A Randomized Controlled Trial Galina Velikova, Laura Booth, Adam B. Smith et al. · Journal of Clinical Oncology 13 Feb 2004 1,421
8 Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data Michel P. Coleman et al. · The Lancet Open access 22 Dec 2010 1,131
9 Large-scale genotyping identifies 41 new loci associated with breast cancer risk Kyriaki Michailidou et al. · Nature Genetics Open access222 authors 27 Mar 2013 1,109
10 CD133, a novel marker for human prostatic epithelial stem cells Gavin David Richardson, Craig N. Robson, Shona Lang et al. · Journal of Cell Science Open access 30 Jun 2004 769
11 Adjuvant Ovarian Suppression in Premenopausal Breast Cancer Prudence A. Francis et al. · New England Journal of Medicine Open access 11 Dec 2014 736
12 Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database Jan Franko, Qian Shi, Jeffrey P. Meyers et al. · The Lancet Oncology Open access 16 Oct 2016 686
13 Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction Brendan Smith, Peter John Selby, Jennifer Southgate et al. · The Lancet Nov 1991 646
14 MicroRNA Related Polymorphisms and Breast Cancer Risk Sofia Khan et al. · PLoS ONE Open access164 authors 12 Nov 2014 638
15 Bone health in cancer patients: ESMO Clinical Practice Guidelines Robert Edward Coleman, Jean‐Jacques Body, Matti Aapro et al. · Annals of Oncology Open access 29 Apr 2014 572
16 Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array Rosalind A. Eeles et al. · Nature Genetics Open access146 authors 27 Mar 2013 551
17 Germline mutations in RAD51D confer susceptibility to ovarian cancer Chey Loveday et al. · Nature Genetics Open access 7 Aug 2011 547
18 Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer Australian Cancer Study et al. · Nature Genetics Open access443 authors 27 Mar 2013 544
19 Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases James R. Berenson, Lee S. Rosen, Anthony Howell et al. · Cancer Open access 2001 532
20 Excision Margins in High-Risk Malignant Melanoma Joseph Meirion Thomas, Julia Newton‐Bishop, Roger A’Hern et al. · New England Journal of Medicine 18 Feb 2004 502
21 ROLE OF N-ACETYLTRANSFERASE PHENOTYPES IN BLADDER CARCINOGENESIS: A PHARMACOGENETIC EPIDEMIOLOGICAL APPROACH TO BLADDER CANCER RaymondA Cartwright, HowardJ. Rogers, D Barham-Hall et al. · The Lancet Oct 1982 494
22 Myocardial Infarction Mortality Risk After Treatment for Hodgkin Disease: A Collaborative British Cohort Study Anthony J. Swerdlow, Craig D. Higgins, Paul Smith et al. · JNCI Journal of the National Cancer Institute 6 Feb 2007 457
23 Understanding Optimal Colonic Cancer Surgery: Comparison of Japanese D3 Resection and European Complete Mesocolic Excision With Central Vascular Ligation Nicholas Paul West, Hirotoshi Kobayashi, Keiichi Takahashi et al. · Journal of Clinical Oncology Open access 3 Apr 2012 433
24 Genome-wide association studies identify four ER negative–specific breast cancer risk loci The Gene ENvironmental Interaction and breast CAncer (GENICA) Network et al. · Nature Genetics Open access274 authors 27 Mar 2013 422
25 EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectum Cornelis J.�H. van de Velde et al. · European Journal of Cancer 31 Oct 2013 409
26 Influence of clinician workload and patterns of treatment on survival from breast cancer Richard Sainsbury, Raymond Haward, C. Round et al. · The Lancet May 1995 381
27 Predisposing Gene for Early-Onset Prostate Cancer, Localized on Chromosome 1q42.2-43 Philippe Berthon et al. · The American Journal of Human Genetics Open access Jun 1998 364
28 Identification and isolation of human prostate epithelial stem cells based on α2β1-integrin expression Anne T. Collins, Fouad K. Habib, Norman J. Maitland et al. · Journal of Cell Science Nov 2001 359
29 Prostate Cancer Stem Cells: A New Target for Therapy Norman J. Maitland, Anne T. Collins · Journal of Clinical Oncology 6 Jun 2008 353
30 Lack of communication between healthcare professionals and women with ovarian cancer about sexual issues Maxine L. Stead, Julia M. Brown, Lesley J. Fallowfield et al. · British Journal of Cancer Open access Mar 2003 351
31 Automated Collection of Quality-of-Life Data: A Comparison of Paper and Computer Touch-Screen Questionnaires Galina Velikova, Penny Wright, Adam B. Smith et al. · Journal of Clinical Oncology Mar 1999 346
32 Liver transplantation for hepatoblastoma: Results from the International Society of Pediatric Oncology (SIOP) study SIOPEL‐1 and review of the world experience Jean Bernard Otte, Jon Pritchard, Daniël C. Aronson et al. · Pediatric Blood & Cancer 25 Nov 2003 343
33 Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results Robert Edward Coleman, Richard de Boer, Holger Eidtmann et al. · Annals of Oncology Open access 10 Oct 2012 341
34 Analysis of apoptosis in the preimplantation bovine embryo using TUNEL Annette T. Byrne, Jennifer Southgate, Daniel R. Brison et al. · Reproduction Sep 1999 335
35 Correlation of DNA adduct levels in human lung with cigarette smoking David H. Phillips, Alan J. Hewer, Carl N. Martin et al. · Nature Dec 1988 309
36 Pretreatment prognostic factors for children with hepatoblastoma — results from the International Society of Paediatric Oncology (SIOP) Study SIOPEL 1 Julia M. Brown, Giorgio Perilongo, E. Shafford et al. · European Journal of Cancer Jul 2000 307
37 Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International society of paediatric oncology (SIOP) and the (German) society of paediatric oncology (GPO): SIOP II C. C. Bailey, Astrid Katharina Gnekow, Stefan Wellek et al. · Medical and Pediatric Oncology Sep 1995 306
38 Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial Robert Edward Coleman, David Cameron, David John Dodwell et al. · The Lancet Oncology 14 Jul 2014 300
39 Benign prostatic hyperplasia – what do we know? Conor M. Devlin, Matthew S. Simms, Norman J. Maitland · British Journal of Urology Open access 14 Sep 2020 297
40 Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies Rosamonde Elizabeth Banks, AJ Gearing, IK Hemingway et al. · British Journal of Cancer Open access Jul 1993 293
41 Impact of the COVID-19 pandemic on the symptomatic diagnosis of cancer: the view from primary care Daniel J Jones, Richard David Neal, Sean Duffy et al. · The Lancet Oncology Open access 30 Apr 2020 283
42 Isolation and characterization of primordial follicles from fresh and cryopreserved human ovarian tissue Kutluk Oktay, David A. Nugent, Helen Newton et al. · Fertility and Sterility Open access Mar 1997 273
43 An international, multicentre, prospective, randomised, controlled, unblinded, parallel-group trial of robotic-assisted versus standard laparoscopic surgery for the curative treatment of rectal cancer Fiona Jane Collinson, David George Jayne, Alessio Pigazzi et al. · International Journal of Colorectal Disease 12 Sep 2011 255
44 27 The Loss of Bone with Age, Osteoporosis, and Fractures Hugh F. Newton‐John, D. BRIAN MORGAN · Clinical Orthopaedics and Related Research Jul 1970 250
45 Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer Neil E. Martin et al. · European Urology Open access 16 Sep 2014 241
46 Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype*1 Alex Sparreboom · Clinical Pharmacology & Therapeutics Jul 2004 240
47 Cardiac Dose From Tangential Breast Cancer Radiotherapy in the Year 2006 Carolyn W. Taylor, Julie Povall, Paul McGale et al. · International Journal of Radiation Oncology*Biology*Physics 19 Apr 2008 238
48 Defining and Measuring Reproductive Concerns of Female Cancer Survivors Lari B. Wenzel · JNCI Monographs Open access Mar 2005 223
49 Testing of some azo dyes and their reduction products for mutagenicity using Salmonella typhimurium TA 1538 R. Colin Garner, Carol A. Nutman · Mutation research. Fundamental and molecular mechanisms of mutagenesis Jul 1977 222
50 THE BIOLOGY OF CELL DEATH IN TUMOURS E.H. Cooper · Cell Proliferation 1973 222

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.